While gastrointestinal issues are the most common side effects, a recent study by the University of British Columbia linked ...
Originally developed to treat Type 2 diabetes, glucagon-like peptide 1 (GLP-1s) are now being studied to explore their ...
Hone Health reports that, when it comes to slowing aging and extending lifespan, few interventions are as well-supported by ...
Hims & Hers is expanding access to Eli Lilly's branded weight loss drug Zepbound and diabetes drug Mounjaro as well as ...
The recent uptick and rise in popularity of GLP-1 drugs for addressing weight loss and obesity has led to an increase in U.S. litigation ...
Here's everything you need to know about the new weight loss medication being rolled out by the NHS to treat obesity.
People seem to be less impressed when others lose weight with the drug Ozempic than when they achieve it via lifestyle ...
A new analysis of FDA adverse event reports suggests a potential link between tirzepatide and thyroid cancer. Learn what this ...
TMS, and gene therapy offer hope for alcohol addiction recovery. Discover how these options could change addiction treatment.
The effect of glucagon-like peptide 1 receptor agonists on patients with joint infections was a popular topic at the American ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results